ストックスクリーナーアプリを入手
210.91
3.56%
7.26
West Pharmaceutical Services Inc (WST) 最新ニュース
West Pharmaceutical Services Declares $0.21 Dividend for Q2 2025 - MyChesCo
Top 2 Health Care Stocks That May Rocket Higher This Month - Benzinga
West Pharmaceutical sets Q2 dividend at $0.21 per share By Investing.com - Investing.com Australia
Insider Decision Unfolding At West Pharmaceutical Servs: Eric Green Exercises Options, Resulting In $0 - Benzinga
Chad Winters Decides To Exercise Options At West Pharmaceutical Servs Worth $0 - Benzinga
Options Exercise Update At West Pharmaceutical Servs: Kimberly MacKay Engages, Resulting In $0 - Benzinga
Engaging In Insider Activity, Cindy Reiss-Clark At West Pharmaceutical Servs Exercises Options Worth $0 - Benzinga
West Pharmaceutical Services, Inc. Announces Second Quarter 2025 Dividend, Payable on May 7, 2025 - Marketscreener.com
West Announces Second-Quarter Dividend - The Malaysian Reserve
West Pharmaceutical sets Q2 dividend at $0.21 per share - Investing.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $240 From $393, Maintains Buy Rating - Marketscreener.com
WEST PHARMACEUTICAL SERVICES INC SEC 10-K Report - TradingView
Wall Street Bounces Back: Top-Performing ETFs Of Last Week - Benzinga
Why Did West Pharmaceutical Services Stock Drop Almost 40%? - Nasdaq
Why West Pharmaceutical Services (WST) Crashed Last Week? - MSN
West Pharmaceutical Services Reports Strong Q4, Introduces 2025 Financial Guidance - MSN
WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down - MSN
West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities (NYSE:WST) - Seeking Alpha
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin - MSN
Reddit, GoDaddy & Trade Desk Are Among Top 11 Large-Cap Losers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? - Benzinga
West Pharmaceutical Services, Inc. (NYSE:WST) Just Reported, And Analysts Assigned A US$306 Price Target - Yahoo Finance UK
West Pharma upgraded at Deutsche Bank despite earnings led selloff - MSN
West Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue - Medical Dialogues
Why West Pharmaceutical Services, Inc. (WST) Went Down on Thursday - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Stock Position Raised by Van ECK Associates Corp - MarketBeat
Consolidated Planning Corp Buys 2,051 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharma stock falls as 2025 guidance disappoints - MSN
KeyCorp Has Lowered Expectations for West Pharmaceutical Services (NYSE:WST) Stock Price - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical Services (NYSE:WST) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
West Pharmaceutical Services, Inc.'s (NYSE:WST) Popularity With Investors Under Threat As Stock Sinks 35% - Simply Wall St
West Pharmaceutical Services (NYSE:WST) Rating Increased to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to Buy - MarketBeat
West Pharma’s Stock Plummets 38% as 2025 Outlook Disappoints Investors - PUNE.NEWS
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN
Dynavax Technologies Corporation Enters into an Agreement with West Pharmaceutical Services, Inc - Marketscreener.com
Sector Update: Health Care Stocks Decline Late Afternoon -February 14, 2025 at 03:59 pm EST - Marketscreener.com
West Pharmaceutical Services (NYSE:WST) Issues Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Sector Update: Health Care Stocks Retreat Friday Afternoon -February 14, 2025 at 01:59 pm EST - Marketscreener.com
Why West Pharmaceutical Shares Are on the Rise Again - TipRanks
West Earnings: Valuation Lowered After Guidance Disappoints and Recovery Trajectory Delayed - Morningstar
West Pharmaceutical Servs's Options Frenzy: What You Need to Know - Benzinga
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
Stock Market Surge: Tesla, Nvidia, and Other Mega-Cap Movers Drive Market Dynamics While West Pharma and Trade Desk Struggle – market - HPBL
KeyBanc Adjusts Price Target on West Pharmaceutical Services to $325 From $470 - Marketscreener.com
West Pharmaceutical Services (NYSE:WST) Reaches New 52-Week LowWhat's Next? - MarketBeat
West Pharmaceutical Services Stock Touches 'Attractive Entry Point,' Deutsche Bank Says - Marketscreener.com
West Pharma stock upgraded at Deutsche Bank (WST:NYSE) - Seeking Alpha
West Pharmaceutical forecasts 2025 results below expectations, shares drop - MSN
West Pharmaceutical Services (NYSE:WST) Updates FY 2025 Earnings Guidance - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript - Insider Monkey
West Pharmaceutical price target lowered to $325 from $470 at KeyBanc - TipRanks
Sumitomo Mitsui Trust Group Inc. Has $58.75 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharma (WST) Stock Leads S&P 500 Rout with 38% Slump - TipRanks
West Pharmaceutical Services Inc (WST) Q4 2024 Earnings Call Highlights: Navigating Growth and ... - Yahoo Finance
West Pharmaceutical stock hits 52-week low at $247.72 By Investing.com - Investing.com Nigeria
West Pharmaceutical Services (WST) Stock Drops After Earnings Re - GuruFocus.com
West Pharmaceutical Services Reports Modest Q4 Growth - TipRanks
West Pharmaceutical Services, Inc. Earnings Call Analysis - TipRanks
West Pharmaceutical Services Inc (WST) Q4 2024 Earnings: EPS of - GuruFocus.com
West Pharmaceutical targets 2-3% organic sales growth for 2025, highlights GLP-1 market expansion - MSN
0.26%
3.85%
大文字化:
|
ボリューム (24 時間):